Approval · Notice of Compliance 19795 · 2017
DYMISTA: Notice of Compliance 19795
Issued September 12, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19795
- Date
- September 12, 2017
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Administrative - Merger/Buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DYMISTA | Not yet assigned | — |
Medicinal ingredients
- FLUTICASONE PROPIONATE 50 MCG per ACT
- AZELASTINE HYDROCHLORIDE 137 MCG per ACT